The EU Commission sends statements of objections to more than a dozen companies concerning investigations in the pharmaceutical sector (Citalopram / Perindopril)

European Commission issues Statements of Objections against several pharmaceutical companies* On 25 and 30 July 2012, in relation to the Citalopram case and the Perindopril case respectively, the European Commission sent statements of objections (“SOs”) to more than a dozen companies in connection with these two antitrust investigations in the pharmaceutical sector. The Commission also issued a note highlighting its current enforcement action in pharmaceutical sector

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Gabriele Accardo, The EU Commission sends statements of objections to more than a dozen companies concerning investigations in the pharmaceutical sector (Citalopram / Perindopril), 30 July 2012, e-Competitions Intellectual property, Art. N° 58426

Visites 290

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues